MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 565470 | Name: ONO-AE1-259 lysine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ONO-AE1-259 is a highly selective agonist of prostaglandin e2 receptor (ep2)

Chemical Structure

ONO-AE1-259 lysine
ONO-AE1-259 lysine
CAS#433232-03-2 (lysine)

Theoretical Analysis

MedKoo Cat#: 565470

Name: ONO-AE1-259 lysine

CAS#: 433232-03-2 (lysine)

Chemical Formula: C29H49ClN2O6

Exact Mass: 410.2224

Molecular Weight: 557.17

Elemental Analysis: C, 62.52; H, 8.86; Cl, 6.36; N, 5.03; O, 17.23

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
365497-70-7 (free acid) 433232-03-2 (lysine)
Synonym
ONO-AE1-259; ONO AE1 259; ONOAE1259; ONO-AE1-259 lysine;
IUPAC/Chemical Name
L-lysine compound with (Z)-7-((1R,2R,3R,5R)-2-((S,E)-4-(1-allylcyclobutyl)-4-hydroxybut-1-en-1-yl)-5-chloro-3-hydroxycyclopentyl)hept-5-enoic acid (1:1)
InChi Key
ROJLEPZSCOJFJA-GGWYBGJWSA-N
InChi Code
InChI=1S/C23H35ClO4.C6H14N2O2/c1-2-13-23(14-8-15-23)21(26)11-7-10-18-17(19(24)16-20(18)25)9-5-3-4-6-12-22(27)28;7-4-2-1-3-5(8)6(9)10/h2-3,5,7,10,17-21,25-26H,1,4,6,8-9,11-16H2,(H,27,28);5H,1-4,7-8H2,(H,9,10)/b5-3-,10-7+;/t17-,18-,19-,20-,21+;5-/m10/s1
SMILES Code
O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/C[C@H](O)C2(CC=C)CCC2)[C@H](O)C[C@H]1Cl.N[C@@H](CCCCN)C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 557.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Michael JV, Gavrila A, Nayak AP, Pera T, Liberato JR, Polischak SR, Shah SD, Deshpande DA, Penn RB. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle. FASEB J. 2019 Apr;33(4):4780-4789. doi: 10.1096/fj.201801959R. Epub 2019 Jan 2. PubMed PMID: 30601680; PubMed Central PMCID: PMC6436661. 2: Bassiouni W, Daabees T, Norel X, Senbel AM. Hypoactivity of rat detrusor muscle in a model of cystitis: exacerbation by non-selective COX inhibitors and amelioration by a selective DP(1) receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol. 2019 Apr;392(4):437-450. doi: 10.1007/s00210-018-01599-7. Epub 2018 Dec 14. PubMed PMID: 30552456. 3: Ota H, Katanosaka K, Murase S, Furuyashiki T, Narumiya S, Mizumura K. EP2 receptor plays pivotal roles in generating mechanical hyperalgesia after lengthening contractions. Scand J Med Sci Sports. 2018 Mar;28(3):826-833. doi: 10.1111/sms.12954. Epub 2017 Aug 11. PubMed PMID: 28759126. 4: Santos AC, Temp FR, Marafiga JR, Pillat MM, Hessel AT, Ribeiro LR, Miyazato LG, Oliveira MS, Mello CF. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity. Epilepsy Behav. 2017 Aug;73:180-188. doi: 10.1016/j.yebeh.2017.03.033. Epub 2017 Jun 20. PubMed PMID: 28645087. 5: Tsuji T, Yamaguchi K, Kikuchi R, Nakamura H, Misaka R, Nagai A, Aoshiba K. Improvement of metabolic disorders by an EP(2) receptor agonist via restoration of the subcutaneous adipose tissue in pulmonary emphysema. Prostaglandins Other Lipid Mediat. 2017 May;130:16-22. doi: 10.1016/j.prostaglandins.2017.03.001. Epub 2017 Mar 2. PubMed PMID: 28263859. 6: Nagano T, Nishiyama R, Sanada A, Mutaguchi Y, Ioku A, Umeki H, Kishimoto S, Yamanaka D, Kimura SH, Takemura M. Prostaglandin E(2) potentiates interferon-γ-induced nitric oxide production in cultured rat microglia. J Neurochem. 2017 Feb;140(4):605-612. doi: 10.1111/jnc.13926. Epub 2017 Feb 2. PubMed PMID: 27973680. 7: Jones VC, Birrell MA, Maher SA, Griffiths M, Grace M, O'Donnell VB, Clark SR, Belvisi MG. Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. Br J Pharmacol. 2016 Mar;173(6):992-1004. doi: 10.1111/bph.13400. PubMed PMID: 26639895; PubMed Central PMCID: PMC4831025. 8: Konya V, Maric J, Jandl K, Luschnig P, Aringer I, Lanz I, Platzer W, Theiler A, Bärnthaler T, Frei R, Marsche G, Marsh LM, Olschewski A, Lippe IT, Heinemann A, Schuligoi R. Activation of EP(4) receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function. Br J Pharmacol. 2015 Sep;172(18):4454-4468. doi: 10.1111/bph.13229. Epub 2015 Jul 31. PubMed PMID: 26103450; PubMed Central PMCID: PMC4562507. 9: Birrell MA, Bonvini SJ, Wortley MA, Buckley J, Yew-Booth L, Maher SA, Dale N, Dubuis ED, Belvisi MG. The role of adenylyl cyclase isoform 6 in β-adrenoceptor signalling in murine airways. Br J Pharmacol. 2015 Jan;172(1):131-41. doi: 10.1111/bph.12905. Epub 2014 Nov 24. PubMed PMID: 25205328; PubMed Central PMCID: PMC4280973. 10: Tsuji T, Yamaguchi K, Kikuchi R, Itoh M, Nakamura H, Nagai A, Aoshiba K. Promotion of adipogenesis by an EP2 receptor agonist via stimulation of angiogenesis in pulmonary emphysema. Prostaglandins Other Lipid Mediat. 2014 Aug;112:9-15. doi: 10.1016/j.prostaglandins.2014.05.003. Epub 2014 Jun 6. PubMed PMID: 24911647. 11: Seki K, Hisada T, Kawata T, Kamide Y, Dobashi K, Yamada M, Mori M, Okajima F, Ishizuka T. Oxidative stress potentially enhances FcεRI-mediated leukotriene C4 release dependent on the late-phase increase of intracellular glutathione in mast cells. Biochem Biophys Res Commun. 2013 Sep 27;439(3):357-62. doi: 10.1016/j.bbrc.2013.08.081. Epub 2013 Aug 30. PubMed PMID: 23998930. 12: Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Clin Exp Allergy. 2013 Jul;43(7):741-51. doi: 10.1111/cea.12142. PubMed PMID: 23786281. 13: Jones RL, Wan Ahmad WA, Woodward DF, Wang J. Nature of the slow relaxation of smooth muscle induced by a EP2 receptor agonist with a non-prostanoid structure. Prostaglandins Leukot Essent Fatty Acids. 2013 Apr;88(4):321-30. doi: 10.1016/j.plefa.2013.01.007. Epub 2013 Feb 16. PubMed PMID: 23419768. 14: Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Am J Respir Cell Mol Biol. 2013 Mar;48(3):322-9. doi: 10.1165/rcmb.2012-0158OC. Epub 2012 Dec 6. PubMed PMID: 23221043. 15: Birrell MA, Maher SA, Buckley J, Dale N, Bonvini S, Raemdonck K, Pullen N, Giembycz MA, Belvisi MG. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor. Br J Pharmacol. 2013 Jan;168(1):129-38. doi: 10.1111/j.1476-5381.2012.02088.x. PubMed PMID: 22747912; PubMed Central PMCID: PMC3570009. 16: Ueta M, Sotozono C, Yokoi N, Kinoshita S. Downregulation of monocyte chemoattractant protein 1 expression by prostaglandin E(2) in human ocular surface epithelium. Arch Ophthalmol. 2012 Feb;130(2):249-51. doi: 10.1001/archopthalmol.2011.1472. PubMed PMID: 22332224. 17: Nakanishi M, Sato T, Li Y, Nelson AJ, Farid M, Michalski J, Kanaji N, Wang X, Basma H, Patil A, Goraya J, Liu X, Togo S, L Toews M, Holz O, Muller KC, Magnussen H, Rennard SI. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts. Am J Respir Cell Mol Biol. 2012 Feb;46(2):217-23. doi: 10.1165/rcmb.2010-0115OC. PubMed PMID: 22298530; PubMed Central PMCID: PMC3297165. 18: Benyahia C, Gomez I, Kanyinda L, Boukais K, Danel C, Leséche G, Longrois D, Norel X. PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy? Pulm Pharmacol Ther. 2012 Feb;25(1):115-8. doi: 10.1016/j.pupt.2011.12.012. Epub 2012 Jan 6. PubMed PMID: 22244823. 19: Buckley J, Birrell MA, Maher SA, Nials AT, Clarke DL, Belvisi MG. EP4 receptor as a new target for bronchodilator therapy. Thorax. 2011 Dec;66(12):1029-35. doi: 10.1136/thx.2010.158568. Epub 2011 May 23. PubMed PMID: 21606476; PubMed Central PMCID: PMC3221321. 20: Mori A, Ito S, Morioka M, Aso H, Kondo M, Sokabe M, Hasegawa Y. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells. Eur J Pharmacol. 2011 May 20;659(1):72-8. doi: 10.1016/j.ejphar.2011.03.001. Epub 2011 Mar 17. PubMed PMID: 21397595.